Free Trial

Nutex Health (NASDAQ:NUTX) Shares Gap Down - What's Next?

Nutex Health logo with Medical background

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price gapped down before the market opened on Monday . The stock had previously closed at $123.54, but opened at $120.00. Nutex Health shares last traded at $120.41, with a volume of 40,999 shares traded.

Analysts Set New Price Targets

Separately, Maxim Group lifted their target price on shares of Nutex Health from $75.00 to $100.00 and gave the stock a "buy" rating in a report on Tuesday, April 8th.

Get Our Latest Research Report on Nutex Health

Nutex Health Trading Down 2.8 %

The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The stock has a market cap of $633.67 million, a P/E ratio of -12.21 and a beta of 0.27. The business's 50 day simple moving average is $83.95 and its 200 day simple moving average is $53.27.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $81.30 million during the quarter, compared to analyst estimates of $81.13 million.

Insider Buying and Selling

In related news, CFO Jon Christian Bates purchased 1,000 shares of the stock in a transaction dated Tuesday, April 8th. The stock was bought at an average cost of $81.81 per share, with a total value of $81,810.00. Following the purchase, the chief financial officer now directly owns 4,888 shares in the company, valued at $399,887.28. The trade was a 25.72 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 38.52% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Nutex Health

Several institutional investors have recently modified their holdings of NUTX. Topline Capital Management LLC acquired a new stake in shares of Nutex Health in the 4th quarter valued at about $5,690,000. American Century Companies Inc. bought a new stake in Nutex Health in the 4th quarter valued at approximately $1,362,000. Ancora Advisors LLC acquired a new position in Nutex Health during the 4th quarter worth approximately $1,334,000. Drive Wealth Management LLC bought a new position in shares of Nutex Health during the 4th quarter worth approximately $1,122,000. Finally, Essex Investment Management Co. LLC raised its holdings in shares of Nutex Health by 45.4% in the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after purchasing an additional 33,024 shares during the last quarter. Institutional investors own 5.32% of the company's stock.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Recommended Stories

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines